Company / Free Cash Flow per Share
Idexx Laboratories Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$12.95
FY2025
5-year range
$4.66 / $12.95
FY2021-FY2025
Trend
+33.1%
vs FY2024
Sector context
#13 of 142
Health Care
What the data says
Among 142 Health Care companies, Idexx Laboratories is in the top 9% for free cash flow per share. Free Cash Flow per Share has increased for 3 consecutive years, from $4.66 in FY2022 to $12.95 in FY2025.
Based on SEC 10-K filings.
12.95 in FY2025 with a 5-year CAGR of +15.4%. Top quartile in the Health Care sector.
Improved from $9.32 to $12.95 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +40.6%
- 5-Year CAGR
- +15.4%
- 10-Year CAGR
- -
Sector benchmark
+150.8% above sector average
Key checks
Key Insights
- Idexx Laboratories's free cash flow per share has grown for 3 consecutive years.
- In FY2025, free cash flow per share increased 33.1% year-over-year.
- Ranks #13 out of 142 companies in the Health Care sector.
- Lowest free cash flow per share in the period was in FY2016.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 4.60 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.6%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 65.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $12.95 | +33.1% |
| FY2024 | $9.73 | +4.4% |
| FY2023 | $9.32 | +100.0% |
| FY2022 | $4.66 | -37.4% |
| FY2021 | $7.44 | +17.6% |
| FY2020 | $6.33 | +79.2% |
| FY2019 | $3.53 | +8.2% |
| FY2018 | $3.26 | +2.3% |
| FY2017 | $3.19 | +18.2% |
| FY2016 | $2.70 | +110.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026